Daniel Marshak

RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA.

Part of Ferghana Partners Group, Ferghana Partners, Inc. operates as an investment banking firm. The company is based in New York, NY. The CEO of the company is William J. Kridel.

Upside Biotechnologies Ltd. provides treatment for severe burns. The firm offers treatment for regenerative medicine, full-thichness skin and major burns. The company was founded in 2016 and is headquartered in Victoria Street West, New Zealand.

Lifevault Bio provides personal biobanking services. It engages in collecting and storing stem cells, DNA and blood plasma for future diagnostic and therapeutic purposes. The company was founded by Trevor Perry, Brad Hamilton and David T. Scadden and is headquartered in Waltham, MA.

Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming.

Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA.

Phase Scientific International Ltd. is a Chinese biotech company that was founded by a team of bioengineers from UCLA. The private company is based in an undisclosed location, but has research and development, manufacturing, and distribution in Hong Kong and China, as well as additional offices in mainland China. The company is focused on building tools that empower people by giving them better information about their health. The company provides novel diagnostic tools and services for cancer and infectious diseases, like COVID-19, with their proprietary technologies. The company was founded by Ricky Chiu and he has been the CEO since incorporation.

Esco Lifesciences Group Ltd. is a multinational life sciences company, engages in the development, manufacture, and sale of life sciences, pharmaceutical and bioprocessing tools as well as the offering of related after-sales and support services. It operates through the following segments: Esco Scientific, Esco Medical, Esco Healthcare, and Esco Services. The Esco Scientific segment provides mission critical life sciences laboratory equipment such as biological safety cabinets, laminar flow clean benches, CO2 and CO2/O2 incubators, fume hoods, centrifuges and others used in research, clinical and industrial settings for preparation, cultivation, handling and analytical purposes. The Esco Medical segment manufactures and sells medical devices such as incubators, workstations, and consumables for IVF treatment. The Esco Healthcare segment provides pharmaceutical equipment and bioprocessing tools, primarily containment and isolation systems for the production of medicines, vaccines, and cell and gene therapies. The Esco Services segment offers after-sales and support services to customers of Esco Scientific, Esco Medical, and Esco Healthcare. The company was founded on February 1, 2021 and is headquartered in Singapore.